Bridgeway Capital Management, LLC Cv Rx, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.67 - $33.01 $277,746 - $785,638	-23,800 Reduced 78.55%	6,500 $204,000
Q3 2023 Nov 14, 2023	SELL	$13.56 - $18.47 $387,748 - $528,149	-28,595 Reduced 48.55%	30,300 $459,000
Q2 2023 Aug 14, 2023	BUY	$8.57 - $15.44 $185,112 - $333,504	21,600 Added 57.92%	58,895 $909,000
Q3 2022 Nov 14, 2022	BUY	$6.12 - $9.5 $53,244 - $82,650	8,700 Added 30.42%	37,295 $348,000
Q2 2022 Aug 15, 2022	BUY	$4.7 - $7.22 $63,896 - $98,155	13,595 Added 90.63%	28,595 $172,000

Q1 2022 May 16, 2022	BUY	$5.62 - $12.37 $84,300 - $185,550	15,000 New	15,000 $90,000

13.8M

264K

89.3K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $247M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.